Avita Medical (ASX: AVH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Avita Medical Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Avita Medical (ASX: AVH)
Latest News
Broker Notes
These ASX shares can rise 25% to 100%+
Share Gainers
Why AVITA Medical, Catapult, Meridian Energy, and Telix shares are storming higher today
Healthcare Shares
Guess which All Ords ASX healthcare share just rocketed 19% on major FDA news
Small Cap Shares
Analysts say these small cap ASX shares can deliver big returns
Healthcare Shares
2 ASX healthcare shares rocking higher on big news
52-Week Lows
3 ASX shares at 52-week lows or worse
Small Cap Shares
Morgans names the best small cap ASX shares to buy in May
Share Fallers
Why Avita Medical, NextDC, Predictive Discovery, and Star shares are tumbling today
Share Fallers
Why Avita Medical, Cettire, Domino's Pizza, and Star shares are falling today
Share Fallers
Why Avita Medical, Netwealth, Peninsula Energy, and Zip shares are sinking today
Share Fallers
Why did this ASX All Ords stock just crash 16%?
Cheap Shares
3 struggling ASX shares to buy at a discount
Frequently Asked Questions
-
No, AVITA Medical does not pay dividends at this time.
-
AVITA Medical Inc listed on the ASX on 24 June 2020.
-
Yes, as well as being listed on the ASX, AVITA Medical Inc is listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.
AVH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Avita Medical
AVITA Medical Inc (ASX: AVH) is a healthcare company specialising in regenerative medicine. It is best known for its RECELL system, a burn treatment device that creates 'spray-on skin' from a patient's own skin cells within 30 minutes, avoiding or reducing the need for skin grafts.
The product was originally invented and patented by Western Australian doctor and clinical professor Fiona Wood in 1993.
RECELL is approved for use in Australia, Europe, Canada, China, the Middle East, and Africa. It is also approved for treating adult patients in the US. As well as burns, AVITA Medical has evidence of RECELL's effectiveness for additional skin applications, such as treating chronic and traumatic wounds, scar revision, and vitiligo.
AVITA Medical Inc is domiciled and also listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.